| Customization: | Available |
|---|---|
| Transport Package: | Carton |
| Specification: | injection |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Name | Doxofylline for injection |
| Main Ingredients | Doxofylline |
| Adaptation disease | Dyspnea caused by bronchial asthma, asthmatic chronic bronchitis and other bronchospasm |
| Character | This product is a white or quasi-white freeze-dried lump |
| Dosage | Powder-injection |
| Specification | 0.1g |
| Directions | For adults, 200 mg each time, 12 hours a time, dilute 25% glucose injection to 40 ml slowly intravenous injection, time should be more than 20 minutes, 5 to 10 days as a course of treatment or according to the doctor's advice. Alternatively, add 300 mg of the product into 5% glucose injection or normal saline injection 100 ml, slowly intravenous drip, once a day. |
| Storage | Airtight save |
| Validity | 18 month |
| Origin | China |
| Notice | [Adverse reactions] The use of xanthine derivatives may cause nausea, vomiting, epigastric pain, headache, insomnia, irritability, tachycardia, extrasystole, tachypnea, hyperglycemia, and proteinuria. If excessive use can also appear serious arrhythmia, paroxysmal spasm. This is the initial symptoms of poisoning. At this time, the drug should be suspended for doctor diagnosis and blood concentration monitoring. However, the drug can still be used after the above signs and symptoms of poisoning completely disappear. [Contraindications] It is contraindicated in patients with acute myocardial infarction and lactating women who are allergic to doxofylline or xanthine derivatives. 1. Theophylline drugs vary greatly among individuals. The best dosage and medication method of doxofylline should be selected according to individual condition changes, and blood concentration should be monitored. Patients suffering from heart disease, hypertension, the elderly and severe hypoxia, hyperthyroidism, chronic pulmonary heart disease, cardiac insufficiency, arrhythmia, liver disease, gastrointestinal ulcer, renal insufficiency or co-infection should be used with caution. 2. Doxofylline should not be used together with other xanthine drugs. It is recommended not to drink caffeinated beverages and eat caffeinated foods at the same time. 3. Caution should be exercised when used with ephedrine or other epinephrine. 4. Attention should be paid to monitoring blood concentration when increasing the dosage (effective treatment within the range of 10 μg/ mL, toxic concentration above 20 μg/ mL). |
){kind=link}